Literature DB >> 10705503

Inhibition of human immunodeficiency virus type 1 reverse transcriptase and ribonuclease H activities by constituents of Juglans mandshurica.

B S Min1, N Nakamura, H Miyashiro, Y H Kim, M Hattori.   

Abstract

From the stem-bark of Juglans mandshurica, two new naphthalenyl glucopyranosides, 1,4,8-trihydroxynaphthalene 1-O-[alpha-L-arabinofuranosyl-(1-->6)-beta-D-glucopyranoside] (1) and 1,4,8-trihydroxynaphthalene 1-O-beta-D-[6'-O-(3",5"-dihydroxy-4"-methoxybenzoyl)]glucopyranosi de (4), and two new alpha-tetralonyl glucopyranosides, 4 alpha,5,8-trihydroxy-alpha-tetralone 5-O-beta-D-[6'-O-(3",5"-dihydroxy-4"-methoxybenzoyl)]glucopyranosi de (7) and 4 alpha,5,8-trihydroxy-alpha-tetralone 5-O-beta-D-[6'-O-(3",4",5"-trihydroxybenzoyl)]glucopyranoside (8), were isolated together with three known naphthalenyl glucopyranosides (2, 3 and 5), one alpha-tetralonyl glucopyranoside (6), four flavonoids (9-12), and two galloyl glucopyranosides (13, 14). Amongst the isolated compounds, 1,2,6-trigalloylglucopyranose (13) and 1,2,3,6-tertagalloylglucopyranose (14) exhibited the most potent inhibition of reverse transcriptase (RT) activity with IC50 values of 0.067 and 0.040 microM, respectively, while the latter compound also inhibited ribonuclease H (RNase H) activity with an IC50 of 39 microM, comparable in potency to illimaquinone used as a positive control. 1,4,8-Trihydroxy-naphthalene 1-O-beta-D-glucopyranoside (2), 1,4,8-trihydroxynaphthalene 1-O-beta-D-[6'-O-(4"-hydroxy-3",5"-dimethoxybenzoyl)]glucopyranoside (3) and 8 showed moderate inhibition against both enzyme activities, and inhibitory potency of 2 against RNase H activity (IC50 = 156 microM) was slightly greater than that against the RT activity (IC50 = 290 microM). The inhibitory potencies of 4 alpha,5,8-trihydroxy-alpha-tetralone 5-O-beta-D-[6'-O-(4"-hydroxy-3",5"-dimethoxybenzoyl)] glucopyranoside (6), 7 and 8 against RT activity increased accompanied by an increase in the number of free hydroxyls on the galloyl residues, as represented by the IC50 values of > 500, 330 and 5.8 microM, respectively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705503     DOI: 10.1248/cpb.48.194

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  6 in total

1.  Diversity-oriented solid-phase synthesis and biological evaluation of oligonucleotide hairpins as HIV-1 RT RNase H inhibitors.

Authors:  Rami N Hannoush; Kyung-Lyum Min; Masad J Damha
Journal:  Nucleic Acids Res       Date:  2004-11-29       Impact factor: 16.971

2.  Selective inhibitory DNA aptamers of the human RNase H1.

Authors:  Frédéric Pileur; Marie-Line Andreola; Eric Dausse; Justine Michel; Serge Moreau; Hirofumi Yamada; Sergei A Gaidamakov; Robert J Crouch; Jean-Jacques Toulmé; Christian Cazenave
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

Review 3.  Juglans mandshurica Maxim.: A Review of Its Traditional Usages, Phytochemical Constituents, and Pharmacological Properties.

Authors:  Fei Luan; Ziyan Wang; Yan Yang; Yafei Ji; Haizhen Lv; Keqing Han; Daoheng Liu; Xiaofei Shang; Xirui He; Nan Zeng
Journal:  Front Pharmacol       Date:  2021-01-21       Impact factor: 5.810

4.  Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.

Authors:  Scott R Budihas; Inna Gorshkova; Sergei Gaidamakov; Antony Wamiru; Marion K Bona; Michael A Parniak; Robert J Crouch; James B McMahon; John A Beutler; Stuart F J Le Grice
Journal:  Nucleic Acids Res       Date:  2005-03-01       Impact factor: 16.971

5.  Biological Activities of Aerial Parts Extracts of Euphorbia characias.

Authors:  Maria Barbara Pisano; Sofia Cosentino; Silvia Viale; Delia Spanò; Angela Corona; Francesca Esposito; Enzo Tramontano; Paola Montoro; Carlo Ignazio Giovanni Tuberoso; Rosaria Medda; Francesca Pintus
Journal:  Biomed Res Int       Date:  2016-05-24       Impact factor: 3.411

6.  Identification of Polar Constituents in the Decoction of Juglans mandshurica and in the Medicated Egg Prepared with the Decoction by HPLC-Q-TOF MS².

Authors:  Tian-Min Wang; Ying Fu; Wen-Jie Yu; Chen Chen; Xue Di; Hui Zhang; Yan-Jun Zhai; Zheng-Yun Chu; Ting-Guo Kang; Hu-Biao Chen
Journal:  Molecules       Date:  2017-09-01       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.